A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination)

Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Aclidinium bromide;   Drug: Aclidinium bromide/formoterol;   Drug: Other COPD medication Sponsors:   AstraZeneca;   RTI Health Solutions Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials